The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
EQRx, Inc. Common Stock 26886C107 86,320 17,438,465 SH   SOLE   17,438,465 0 0
Erasca, Inc. Common Stock 29479A108 19,500 2,500,000 SH   SOLE   2,500,000 0 0
InVitae Corporation Common Stock 46185L103 3,140 1,276,541 SH   SOLE   1,276,541 0 0
Nautilus Biotechnology, Inc. Common Stock 63909J108 34,552 16,298,006 SH   SOLE   16,298,006 0 0